Comprehensive Comparisons of Different Treatments for Active Graves Orbitopathy: A Systematic Review and Bayesian Model–Based Network Meta-Analysis
Lists
Only you see this
Abstract
Teprotumumab emerges as potentially the most effective treatment for reducing inflammation and increasing overall response rates when compared with no treatment; oral mycophenolate combined with IVGCs appears to be the best for improving proptosis. While some treatments raise safety concerns due to reported adverse events, oral methotrexate combined with IVGCs appear to offer a favorable balance between efficacy and safety among the evaluated treatments.
BibTeX
@article{xu2024comprehensive,
author = {Yanlin Xu and Ruikang Liu and Liying Huang and You Qin and Shiyuan Liu and Shu-Ting Huang and Jiaoyue Zhang},
title = {{Comprehensive Comparisons of Different Treatments for Active Graves Orbitopathy: A Systematic Review and Bayesian Model–Based Network Meta-Analysis}},
journal = {The Journal of Clinical Endocrinology \& Metabolism},
year = {2024},
doi = {10.1210/clinem/dgae877},
}Loading related content...